Anika Therapeutics
Price & Volume
Stats
See more52W Range | $7.87-$16.49 |
Market Cap | $207.5M |
Shares Short | 416,970 |
Financials
See moreRevenue (12 Mos) | $116.2M |
Revenue Growth (YoY) | 13.2% |
Gross Profit (12 Mos) | $68.1M |
Diluted EPS | -$0.79 |
News
See moreYahoo Finance • last month
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 2 months ago
Anika Therapeutics, Inc. Q1 2026 Earnings Call Summary
Yahoo Finance • 3 months ago
Anika Reports First Quarter 2026 Financial Results
Yahoo Finance • 3 months ago
Anika (ANIK) Q2 2025 Earnings Call Transcript
About
CEO | Mr. Stephen D. Griffin |
Address | 32 Wiggins Avenue, Bedford, MA, United States, 01730 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 235 |